An exploratory clinical study of camrelizumab combined with apatinib mesylate in the treatment of advanced gastrointestinal tumors that have failed the previous standard treatment

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2021
This article has no abstract
Epistemonikos ID: 0d407fdc0b454889902e6722e4c91fb551cc1666
First added on: Apr 08, 2025